Placo: Net profit for the first half of the year is expected to increase by 44.70% to 64.98% compared to the same period last year.

On the evening of July 11th, Plaico disclosed its performance forecast, with the company expecting a net profit attributable to the owners of the parent company of 1.07 billion yuan to 1.22 billion yuan for the first half of 2025, a year-on-year increase of 44.70% to 64.98%. In the first half of 2025, the introduction of new products such as pig pseudorabies live vaccine and adenovirus series avian five-in-one vaccines contributed new growth points for the company, while sales revenue of pet-related products continued to maintain a high growth momentum.